|Base Year Market Size
|USD 22.4 Billion
|Forecast Year Market Size
|USD 34.3 Billion
|Fastest Growing Market
The global vector control market size was valued at USD 22.4 billion in 2022 and is projected to reach USD 34.3 billion by 2031, registering a CAGR of 5.5% during the forecast period (2023-2031). The increasing prevalence of vector-borne diseases, the implementation of efficient control methods, and an increase in awareness of the health concerns posed by vectors are the factors promoting market growth.
Vector control refers to systematic efforts to manage and reduce the population of disease-carrying vectors such as mosquitos, ticks, flies, and other organisms that transmit infectious diseases to humans and animals. These vectors transmit malaria, dengue fever, Zika virus, Lyme disease, and other diseases.
Vector control market share is predicted to expand at a CAGR of 6.1%. In light of the increasing prevalence of vector-borne diseases and the implementation of efficient control methods, the market is expected to grow as people become more aware of the health concerns posed by vectors. During the forecast period, the vector control market is expected to be constrained by a lengthy approval procedure and a lack of common evaluation methodologies. IVM (integrated vector management) is a unique technique for controlling vector-borne illnesses that can be used to improve the effectiveness of current national and international disease control activities.
The rising prevalence of vector-borne diseases is a major driving force in the worldwide vector control industry. The need for effective vector control strategies grows as these diseases plague communities worldwide. Malaria, a mosquito-borne disease that poses a huge public health concern worldwide, is one prominent example. Malaria is a mosquito-borne parasitic infection caused by the Plasmodium parasite. It is spread to humans by the bites of infected Anopheles mosquitos. Malaria is a worldwide disease primarily affecting Sub-Saharan Africa, Southeast Asia, and parts of South America. Malaria is one of the world's most serious health problems, according to the World Health Organization (WHO), with high fatality rates, particularly among children under five. As a result of the rise in these diseases, the vector control market trend is likely to change.
According to the World Health Organization's (WHO) World Malaria Report 2021, there were 229 million malaria cases worldwide in 2019, with an estimated 409,000 fatalities. Sub-Saharan Africa was responsible for roughly 94% of all malaria cases and deaths. Children under five were responsible for 67% of all malaria deaths.
Resistance to insecticides in disease-carrying vectors is a major impediment in the worldwide vector control business. As vectors gain resistance to frequently used pesticides, controlling their numbers and preventing the spread of vector-borne diseases becomes more difficult.
In malaria-endemic areas, insecticide-treated bed nets and indoor residual spraying are critical measures for minimizing mosquito bites and disease transmission. However, mosquitos have resisted specific insecticide classes employed in these interventions over time. Insecticide resistance complicates vector control efforts by reducing the effectiveness of established control measures. This necessitates the development of new techniques and inventive solutions to tackle resistant vectors. To meet this problem, the vector control industry must develop new insecticides, investigate non-chemical control strategies, and implement integrated vector management approaches incorporating multiple treatments. As a result, it hinders the Vector Control Market growth.
IVM is a strategy that integrates numerous tactics and interventions to effectively control disease vectors while limiting their impact on human health, the environment, and non-target species. This holistic strategy for vector control is gaining traction around the world and has the potential to improve public health outcomes significantly. Zambia, a malaria-endemic country in Sub-Saharan Africa, has effectively deployed IVM tactics to suppress the Anopheles mosquitos that transmit malaria. Zambia's National Malaria Elimination Centre (NMEC) adopted IVM as a framework for malaria control activities.
In Zambia, the IVM strategy combines insecticide-treated bed nets, indoor residual spraying, larval source control, and environmental modification. Zambia reported a significant decrease in malaria incidence and deaths in 2018. Malaria cases declined from nearly 4 million in 2014 to under 2 million in 2018. IVM enables adaptation to changing situations, such as altering mosquito behavior or environmental factors. IVM improves public health results and creates partnerships, research, and innovation opportunities in the worldwide vector control sector.
The global vector control market analysis is conducted across North America, Europe, Asia-Pacific, the Middle East and Africa, and Latin America.
North America holds a sizeable global market share and is expected to boost at a CAGR of 5.1% during the forecast period. North America will hold the highest revenue share of the global market in 2022 Because of increased demand for vector control services and products for residential and non-residential applications. The West Nile virus (WNV) is a mosquito-borne disease that has been a major source of worry in North America. The virus is spread to humans by the bites of infected mosquitos. Vector management activities are critical in places where WNV is present to minimize mosquito populations and prevent disease transmission.
Additionally, according to the Centers for Disease Control and Prevention (CDC), West Nile virus was first found in the United States in 1999 and has since evolved into a seasonal epidemic, with incidence peaking in the summer and early fall. Between 1999 and 2020, about 51,000 cases of West Nile virus were documented in the United States, resulting in over 2,300 deaths. To reduce WNV transmission, effective vector management strategies such as mosquito surveillance, larviciding, and public awareness programs are required. Effective vector management in North America necessitates a multifaceted approach involving government agencies, healthcare professionals, researchers, and community involvement. The region's resources and experience position it well to develop and implement solutions to reduce the public health impact of vector-borne diseases.
Asia-Pacific is predicted to rise at a substantial CAGR of 6.1% throughout the forecast period. Due to rapid urbanization, ineffective waste management systems, high occurrences of vector-borne diseases, and rising awareness, the Asia-Pacific regional market is predicted to develop fastest over the forecast period, According to the Market insights. The Asia-Pacific area accounts for most global dengue cases, according to the World Health Organization (WHO). Over 2 million dengue cases were reported in the region in 2019, with substantial numbers in countries like India, Indonesia, and the Philippines. Dengue fever can have serious health consequences, including hospitalizations and deaths, especially in youngsters.
Furthermore, Asia-Pacific countries may collaborate and share best practices to address common vector-borne illness challenges. Combating vector-borne diseases in the Asia-Pacific area necessitates a comprehensive and collaborative approach that considers local settings, involves communities, and adapts techniques to changing disease dynamics.
Europe is home to many vector-borne diseases, including tick-borne illnesses such as Lyme disease and mosquito-borne illnesses such as West Nile virus. Vector control techniques are critical to preventing the spread of these diseases and protecting the region's public health. Lyme borreliosis, caused by the Borrelia bacteria, is the most frequent vector-borne disease in Europe, with thousands of reported cases each year, according to the European Centre for Disease Prevention and Control (ECDC). Climate, land use, and human activity all impact the dispersion of ticks and the diseases they transmit. In Europe, public health agencies and communities collaborate to execute effective vector control methods that minimize the burden of vector-borne diseases and maintain population well-being.
The Middle East and Africa region is plagued by several vector-borne diseases that pose serious health risks to communities. These diseases, spread by mosquitoes, ticks, and flies, necessitate efficient vector control strategies to reduce their public health impact.
|Bayer Syngenta BASF Bell Laboratories FMC Corporation Rentokil Initial Ecolab Terminix International Rollins Anticimex Group Arrow Exterminators Ensystex Impex Europa Liphatech PelGar International
|U.K. Germany France Spain Italy Russia Nordic Benelux Rest of Europe
|China Korea Japan India Australia Singapore Taiwan South East Asia Rest of Asia-Pacific
|Middle East and Africa
|UAE Turkey Saudi Arabia South Africa Egypt Nigeria Rest of MEA
|Brazil Mexico Argentina Chile Colombia Rest of LATAM
|Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
The global vector control market is segmented based on vectors, methods, end-use, application, and region.
Vectors segment is further segmented into insects, rodents, and others.
Insects hold the major share of the market.
Insects are the most well-known and substantial vectors responsible for disease transmission. Mosquitoes, for example, spread diseases such as malaria, dengue fever, the Zika virus, and the West Nile virus. Ticks transmit Lyme disease; Rocky Mountain spotted fever, and other diseases. Furthermore, flies can transfer diseases such as cholera and trachoma.
Rodents, particularly rats and mice, can act as disease vectors directly or indirectly through their parasites. Mice, for example, are known carriers of diseases like hantavirus pulmonary syndrome, leptospirosis, and plague (transmitted by fleas that infest mice).
Based on method, the market is fragmented into chemical, biological, mechanical/physical.
Chemicals led the market growth.
To target and eradicate disease vectors, chemical approaches employ a variety of chemical agents. Insecticides frequently kill or repel vectors such as mosquitoes and flies. These chemicals can be used in various ways, including indoor residual spraying, space spraying, and treating water sources where larvae thrive. Insecticide-treated bed nets are also an important component of chemical vector control since they protect people while they sleep.
Natural enemies or pathogens are used in biological approaches to manage vector populations. This method introduces predators, parasites, or pathogens designed to attack disease vectors. Certain fish species, for example, are put into bodies of water to consume mosquito larvae, while bacteria such as Bacillus thuringiensis (Bt) are used as larvicides.
By end-use, the segment can be further bifurcated into residential and non-residential.
Non-residential end-users are the main income generator.
Non-residential environments are areas where people assemble or work that are not their homes. Schools, hospitals, offices, recreational facilities, and public spaces are all included in this category. Vector control measures in non-residential settings protect people's health and safety while preventing vector-borne diseases.
Residential settings are places where people reside, such as houses, apartment buildings, and communities. Residential vector management approaches attempt to protect persons and families against disease-carrying vectors in and around their living environments. Indoor residual spraying, the distribution of insecticide-treated bed nets, and the elimination of possible breeding areas such as standing water are all common components of residential vector management.